ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 131 filers reported holding ALBANY MOLECULAR RESH INC in Q2 2015. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,921,000 | +56.0% | 134,625 | +0.9% | 0.05% | +51.5% |
| Q1 2017 | $1,873,000 | -24.7% | 133,488 | +0.8% | 0.03% | -29.8% |
| Q4 2016 | $2,486,000 | +17.1% | 132,493 | +3.0% | 0.05% | +9.3% |
| Q3 2016 | $2,123,000 | +57.6% | 128,576 | +28.3% | 0.04% | +48.3% |
| Q2 2016 | $1,347,000 | -9.7% | 100,231 | +2.8% | 0.03% | -12.1% |
| Q1 2016 | $1,491,000 | -52.6% | 97,537 | -38.4% | 0.03% | -53.5% |
| Q4 2015 | $3,144,000 | +20.6% | 158,399 | +5.8% | 0.07% | +14.5% |
| Q3 2015 | $2,608,000 | -41.7% | 149,710 | -32.3% | 0.06% | -36.7% |
| Q2 2015 | $4,471,000 | +21.9% | 221,133 | +6.1% | 0.10% | +22.5% |
| Q1 2015 | $3,668,000 | +8.0% | 208,383 | -0.1% | 0.08% | +5.3% |
| Q4 2014 | $3,397,000 | +640.1% | 208,683 | +903.3% | 0.08% | +590.9% |
| Q3 2014 | $459,000 | – | 20,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 567,400 | $11,473,000 | 12.05% |
| Permian Investment Partners, LP | 1,875,650 | $37,926,000 | 7.67% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 1,490,174 | $30,131,000 | 2.57% |
| AMERICAN CAPITAL MANAGEMENT INC | 993,280 | $20,084,000 | 1.91% |
| Netols Asset Management, Inc. | 387,471 | $7,835,000 | 1.54% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,158,759 | $23,430,000 | 1.35% |
| Evercore Wealth Management, LLC | 1,233,880 | $24,948,000 | 1.13% |
| Visium Asset Management, LP | 3,200,000 | $64,704,000 | 0.92% |
| Granite Investment Partners, LLC | 303,787 | $6,143,000 | 0.57% |
| FRANKLIN STREET ADVISORS INC /NC | 144,125 | $2,914,000 | 0.52% |